Arrowhead Pharmaceuticals Inc. (ARWR) Misses Q3 EPS by 40c
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $87.11 --0%
Financial Fact:
NET INCOME (LOSS): -19.42M
Today's EPS Names:
SQZB, RENO, LUNA, More
Financial Fact:
NET INCOME (LOSS): -19.42M
Today's EPS Names:
SQZB, RENO, LUNA, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q3 EPS of ($1.26), $0.40 worse than the analyst estimate of ($0.86). Revenue for the quarter came in at $27.77 million versus the consensus estimate of $53.9 million.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BTIG Reiterates Neutral Rating on MaxCyte Inc. (MXCT)
- Comstock closes $45M mining asset sale, receives $20M cash
- GE Vernova unveils medium-voltage power supply for data centers
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
